<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34391037</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-5883</ISSN><JournalIssue CitedMedium="Internet"><Volume>428</Volume><PubDate><Year>2021</Year><Month>Sep</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of the neurological sciences</Title><ISOAbbreviation>J Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Emerging potential mechanisms and predispositions to the neurological manifestations of COVID-19.</ArticleTitle><Pagination><StartPage>117608</StartPage><MedlinePgn>117608</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jns.2021.117608</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-510X(21)00302-6</ELocationID><Abstract><AbstractText>A spectrum of neurological disease associated with COVID-19 is becoming increasingly apparent. However, the mechanisms behind these manifestations remain poorly understood, significantly hindering their management. The present review subsequently attempts to address the evolving molecular, cellular and systemic mechanisms of NeuroCOVID, which we have classified as the acute and long-term neurological effects of COVID-19. We place particular emphasis on cerebrovascular, demyelinating and encephalitic presentations, which have been reported. Several mechanisms are presented, especially the involvement of a "cytokine storm". We explore the genetic and demographic factors that may predispose individuals to NeuroCOVID. The increasingly evident long-term neurological effects are also presented, including the impact of the virus on cognition, autonomic function and mental wellbeing, which represent an impending burden on already stretched healthcare services. We subsequently reinforce the need for cautious surveillance, especially for those with predisposing factors, with effective clinical phenotyping, appropriate investigation and, if possible, prompt treatment. This will be imperative to prevent downstream neurological sequelae, including those related to the long COVID phenotypes that are being increasingly recognised.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jesuthasan</LastName><ForeName>Aaron</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University College Hospital, University College London Hospitals NHS Foundation Trust, London, UK. Electronic address: a.jesuthasan@nhs.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Massey</LastName><ForeName>Flavia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University College London Medical School, Gower Street, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manji</LastName><ForeName>Hadi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zandi</LastName><ForeName>Michael S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiethoff</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>UCL Institute of Neurology, Queen Square, London, UK; Klinik f&#xfc;r Neurologie mit Institut f&#xfc;r Translationale Neurologie, Albert Schweitzer Campus 1, Geb&#xe4;ude A1, D-48149 M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Neurol Sci</MedlineTA><NlmUniqueID>0375403</NlmUniqueID><ISSNLinking>0022-510X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000080424" MajorTopicYN="N">Cytokine Release Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="Y">Nervous System Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">NeuroCOVID</Keyword><Keyword MajorTopicYN="N">Neurology</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>MSZ has received honoraria for lecturing from Eisai and UCB Pharma. SW &#x2013; Declarations of interest: none. AJ &#x2013; Declarations of interest: none. FM &#x2013; Declarations of interest: none. HM &#x2013; Declarations of interest: none.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>14</Day><Hour>20</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34391037</ArticleId><ArticleId IdType="pmc">PMC8332920</ArticleId><ArticleId IdType="doi">10.1016/j.jns.2021.117608</ArticleId><ArticleId IdType="pii">S0022-510X(21)00302-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>COVID-19 Map Johns Hopkins Coronavirus Resource Center. 2021. https://coronavirus.jhu.edu/map.html Accessed January 26, 2021.</Citation></Reference><Reference><Citation>Paterson R.W., Brown R.L., Benjamin L., et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2021 doi: 10.1093/brain/awaa240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa240</ArticleId><ArticleId IdType="pmc">PMC7454352</ArticleId><ArticleId IdType="pubmed">32637987</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriguchi T., Harii N., Goto J., et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int. J. Infect. Dis. 2020;94:55&#x2013;58. doi: 10.1016/j.ijid.2020.03.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.062</ArticleId><ArticleId IdType="pmc">PMC7195378</ArticleId><ArticleId IdType="pubmed">32251791</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J., L&#xfc;tgehetmann M., Hagel C., et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19(11):919&#x2013;929. doi: 10.1016/S1474-4422(20)30308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelles V.G., L&#xfc;tgehetmann M., Lindenmeyer M.T., et al. Multiorgan and renal tropism of SARS-CoV-2. N. Engl. J. Med. 2020 doi: 10.1056/NEJMc2011400. Published online May 13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2011400</ArticleId><ArticleId IdType="pmc">PMC7240771</ArticleId><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichard R.R., Kashani K.B., Boire N.A., Constantopoulos E., Guo Y., Lucchinetti C.F. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. (Berl). 2020;140(1):1&#x2013;6. doi: 10.1007/s00401-020-02166-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02166-2</ArticleId><ArticleId IdType="pmc">PMC7245994</ArticleId><ArticleId IdType="pubmed">32449057</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-S&#xe1;nchez C.M., D&#xed;az-Maroto I., Fern&#xe1;ndez-D&#xed;az E., et al. Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology. 2020;95(8):e1060&#x2013;e1070. doi: 10.1212/WNL.0000000000009937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009937</ArticleId><ArticleId IdType="pmc">PMC7668545</ArticleId><ArticleId IdType="pubmed">32482845</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul M., Varatharaj A., Nicholson T.R., et al. Defining causality in COVID-19 and neurological disorders. J. Neurol. Neurosurg. Psychiatry. 2020;91(8):811&#x2013;812. doi: 10.1136/jnnp-2020-323667.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-323667</ArticleId><ArticleId IdType="pmc">PMC7299654</ArticleId><ArticleId IdType="pubmed">32503883</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Xu X., Chen Z., et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav. Immun. 2020;87:18&#x2013;22. doi: 10.1016/j.bbi.2020.03.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.03.031</ArticleId><ArticleId IdType="pmc">PMC7146689</ArticleId><ArticleId IdType="pubmed">32240762</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271&#x2013;280. doi: 10.1016/j.cell.2020.02.052. e8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R., Wang K., Yu J., Chen Z., Wen C., Xu Z. 2020. The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in Human and Mouse Brain. Published online April 9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.07.030650</ArticleId><ArticleId IdType="pmc">PMC7855591</ArticleId><ArticleId IdType="pubmed">33551947</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M., Shen W., Rowan N., et al. Elevated ACE2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication. Biorxiv Prepr. Serv. Biol. 2020 doi: 10.1101/2020.05.08.084996. Published online May 9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.08.084996</ArticleId><ArticleId IdType="pmc">PMC7439429</ArticleId><ArticleId IdType="pubmed">32817004</ArticleId></ArticleIdList></Reference><Reference><Citation>DosSantos M.F., Devalle S., Aran V., et al. Neuromechanisms of SARS-CoV-2: a review. Front. Neuroanat. 2020;14 doi: 10.3389/fnana.2020.00037.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnana.2020.00037</ArticleId><ArticleId IdType="pmc">PMC7308495</ArticleId><ArticleId IdType="pubmed">32612515</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsivgoulis G., Fragkou P.C., Lachanis S., et al. Olfactory bulb and mucosa abnormalities in persistent COVID-19-induced anosmia: a magnetic resonance imaging study. Eur. J. Neurol. 2021;28(1):e6&#x2013;e8. doi: 10.1111/ene.14537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14537</ArticleId><ArticleId IdType="pubmed">32939911</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H., Zhong L., Deng J., et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral Sci. 2020;12(1):8. doi: 10.1038/s41368-020-0074-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41368-020-0074-x</ArticleId><ArticleId IdType="pmc">PMC7039956</ArticleId><ArticleId IdType="pubmed">32094336</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M., et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020 doi: 10.1001/jamaneurol.2020.1127. Published online April 10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad I., Rathore F.A. Neurological manifestations and complications of COVID-19: a literature review. J. Clin. Neurosci. Off J Neurosurg Soc Australas. 2020;77:8&#x2013;12. doi: 10.1016/j.jocn.2020.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2020.05.017</ArticleId><ArticleId IdType="pmc">PMC7200361</ArticleId><ArticleId IdType="pubmed">32409215</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum D.C., June C.H. Cytokine storm. N. Engl. J. Med. 2020;383(23):2255&#x2013;2273. doi: 10.1056/NEJMra2026131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2026131</ArticleId><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Horby P., Lim W.S., et al. RECOVERY Collaborative Group Dexamethasone in hospitalized patients with COVID-19 - preliminary report. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2021436. Published online July 17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang K., Su I., Theron M., et al. An interferon-&#x3b3;-related cytokine storm in SARS patients. J. Med. Virol. 2005;75(2):185&#x2013;194. doi: 10.1002/jmv.20255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20255</ArticleId><ArticleId IdType="pmc">PMC7166886</ArticleId><ArticleId IdType="pubmed">15602737</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin P., Collongues N., Baloglu S., et al. Cytokine release syndrome-associated encephalopathy in patients with COVID-19. Eur. J. Neurol. 2021;28(1):248&#x2013;258. doi: 10.1111/ene.14491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14491</ArticleId><ArticleId IdType="pmc">PMC7461405</ArticleId><ArticleId IdType="pubmed">32853434</ArticleId></ArticleIdList></Reference><Reference><Citation>Esp&#xed;ndola O.M., Gomes Y.C.P., Brand&#xe3;o C.O., et al. Inflammatory cytokine patterns associated with neurological diseases in coronavirus disease 2019. Ann. Neurol. 2021 doi: 10.1002/ana.26041. Published online February 24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26041</ArticleId><ArticleId IdType="pmc">PMC8014707</ArticleId><ArticleId IdType="pubmed">33547819</ArticleId></ArticleIdList></Reference><Reference><Citation>Remsik J., Wilcox J.A., Babady N.E., et al. Inflammatory leptomeningeal cytokines mediate COVID-19 neurologic symptoms in cancer patients. Cancer Cell. 2021;39(2):276&#x2013;283. doi: 10.1016/j.ccell.2021.01.007. e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccell.2021.01.007</ArticleId><ArticleId IdType="pmc">PMC7833316</ArticleId><ArticleId IdType="pubmed">33508216</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia M.A., Barreras P.V., Lewis A., et al. Cerebrospinal fluid in COVID-19 neurological complications: no cytokine storm or neuroinflammation. medRxiv. 2021 doi: 10.1101/2021.01.10.20249014. Published online January 12. 2021.01.10.20249014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.10.20249014</ArticleId><ArticleId IdType="pmc">PMC8166041</ArticleId><ArticleId IdType="pubmed">34090021</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavi E., Cong L. Type I astrocytes and microglia induce a cytokine response in an encephalitic murine coronavirus infection. Exp. Mol. Pathol. 2020;115:104474. doi: 10.1016/j.yexmp.2020.104474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexmp.2020.104474</ArticleId><ArticleId IdType="pmc">PMC7245307</ArticleId><ArticleId IdType="pubmed">32454103</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.-H., Perl D.P., Nair G., et al. Microvascular injury in the brains of patients with COVID-19. N. Engl. J. Med. 2021;384(5):481&#x2013;483. doi: 10.1056/NEJMc2033369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2033369</ArticleId><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur K.T., Miller E.H., Glendinning M.D., et al. COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital. Brain. 2021 doi: 10.1093/brain/awab148. awab148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab148</ArticleId><ArticleId IdType="pmc">PMC8083258</ArticleId><ArticleId IdType="pubmed">33856027</ArticleId></ArticleIdList></Reference><Reference><Citation>Heming M., Li X., R&#xe4;uber S., et al. Neurological manifestations of COVID-19 feature T cell exhaustion and dedifferentiated monocytes in cerebrospinal fluid. Immunity. 2021;54(1):164&#x2013;175. doi: 10.1016/j.immuni.2020.12.011. e6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.12.011</ArticleId><ArticleId IdType="pmc">PMC7831653</ArticleId><ArticleId IdType="pubmed">33382973</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Fu L., Gonzales D.M., Lavi E. Coronavirus Neurovirulence correlates with the ability of the virus to induce proinflammatory cytokine signals from astrocytes and microglia. J. Virol. 2004;78(7):3398&#x2013;3406. doi: 10.1128/JVI.78.7.3398-3406.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.7.3398-3406.2004</ArticleId><ArticleId IdType="pmc">PMC371061</ArticleId><ArticleId IdType="pubmed">15016862</ArticleId></ArticleIdList></Reference><Reference><Citation>Meftahi G.H., Jangravi Z., Sahraei H., Bahari Z. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of &#x201c;inflame-aging&#x201d;. Inflamm. Res. 2020;69(9):825&#x2013;839. doi: 10.1007/s00011-020-01372-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-020-01372-8</ArticleId><ArticleId IdType="pmc">PMC7289226</ArticleId><ArticleId IdType="pubmed">32529477</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh J., Peyssonnaux C., Singh K.K., Edeas M. Mitochondria and microbiota dysfunction in COVID-19 pathogenesis. Mitochondrion. 2020;54:1&#x2013;7. doi: 10.1016/j.mito.2020.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2020.06.008</ArticleId><ArticleId IdType="pmc">PMC7837003</ArticleId><ArticleId IdType="pubmed">32574708</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibellini L., De Biasi S., Paolini A., et al. Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia. EMBO Mol. Med. 2020;12(12) doi: 10.15252/emmm.202013001.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202013001</ArticleId><ArticleId IdType="pmc">PMC7645870</ArticleId><ArticleId IdType="pubmed">33078545</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdennour L., Zeghal C., D&#xe8;me M., Puybasset L. Interaction brain-lungs. Ann. Fr. Anesth. Reanim. 2012;31(6):e101&#x2013;e107. doi: 10.1016/j.annfar.2012.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annfar.2012.04.013</ArticleId><ArticleId IdType="pubmed">22694980</ArticleId></ArticleIdList></Reference><Reference><Citation>Vardhana S.A., Hwee M.A., Berisa M., et al. Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen. Nat. Immunol. 2020;21(9):1022&#x2013;1033. doi: 10.1038/s41590-020-0725-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0725-2</ArticleId><ArticleId IdType="pmc">PMC7442749</ArticleId><ArticleId IdType="pubmed">32661364</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang S. Mitochondrial oxidative phosphorylation is linked to T-cell exhaustion. Aging. 2020;12(17):16665&#x2013;16666. doi: 10.18632/aging.103995.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103995</ArticleId><ArticleId IdType="pmc">PMC7521505</ArticleId><ArticleId IdType="pubmed">32897246</ArticleId></ArticleIdList></Reference><Reference><Citation>LoPresti M., Beck D.B., Duggal P., Cummings D.A.T., Solomon B.D. The role of host genetic factors in coronavirus susceptibility: review of animal and systematic review of human literature. medRxiv. 2020 doi: 10.1101/2020.05.30.20117788. Published online June 3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.30.20117788</ArticleId><ArticleId IdType="pmc">PMC7420067</ArticleId><ArticleId IdType="pubmed">32814065</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y., Zhao J., Martin W., et al. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis. BMC Med. 2020;18(1):216. doi: 10.1186/s12916-020-01673-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01673-z</ArticleId><ArticleId IdType="pmc">PMC7360473</ArticleId><ArticleId IdType="pubmed">32664879</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y., Li L., Feng Z., et al. Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell Discov. 2020;6:11. doi: 10.1038/s41421-020-0147-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-020-0147-1</ArticleId><ArticleId IdType="pmc">PMC7040011</ArticleId><ArticleId IdType="pubmed">32133153</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain M., Jabeen N., Raza F., et al. Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein. J. Med. Virol. 2020 doi: 10.1002/jmv.25832. Published online April 6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25832</ArticleId><ArticleId IdType="pmc">PMC7228372</ArticleId><ArticleId IdType="pubmed">32249956</ArticleId></ArticleIdList></Reference><Reference><Citation>de Cruz J.O., IMCA Concei&#xe7;&#xe3;o, SMB Sousa, Luizon M.R. Functional prediction and frequency of coding variants in human ACE2 at binding sites with SARS-CoV-2 spike protein on different populations. J. Med. Virol. 2020 doi: 10.1002/jmv.26126. Published online June 3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26126</ArticleId><ArticleId IdType="pmc">PMC7300988</ArticleId><ArticleId IdType="pubmed">32492195</ArticleId></ArticleIdList></Reference><Reference><Citation>Asselta R., Paraboschi E.M., Mantovani A., Duga S. ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. Aging. 2020;12(11):10087&#x2013;10098. doi: 10.18632/aging.103415.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103415</ArticleId><ArticleId IdType="pmc">PMC7346072</ArticleId><ArticleId IdType="pubmed">32501810</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaser A. Genetic risk of severe Covid-19. N. Engl. J. Med. 2020;383(16):1590&#x2013;1591. doi: 10.1056/NEJMe2025501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe2025501</ArticleId><ArticleId IdType="pmc">PMC7583681</ArticleId><ArticleId IdType="pubmed">33053291</ArticleId></ArticleIdList></Reference><Reference><Citation>Pairo-Castineira E., Clohisey S., Klaric L., et al. Genetic mechanisms of critical illness in Covid-19. Nature. 2021;591(7848):92&#x2013;98. doi: 10.1038/s41586-020-03065-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-03065-y</ArticleId><ArticleId IdType="pubmed">33307546</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeberg H., P&#xe4;&#xe4;bo S. The major genetic risk factor for severe COVID-19 is inherited from Neanderthals. Nature. 2020;587(7835):610&#x2013;612. doi: 10.1038/s41586-020-2818-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2818-3</ArticleId><ArticleId IdType="pubmed">32998156</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S.-Y., Casanova J.-L. Inborn errors underlying herpes simplex encephalitis: from TLR3 to IRF3. J. Exp. Med. 2015;212(9):1342&#x2013;1343. doi: 10.1084/jem.2129insight4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.2129insight4</ArticleId><ArticleId IdType="pmc">PMC4548049</ArticleId><ArticleId IdType="pubmed">26304982</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Made C.I., Simons A., Schuurs-Hoeijmakers J., et al. Presence of genetic variants among young men with severe COVID-19. JAMA. 2020 doi: 10.1001/jama.2020.13719. Published online July 24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.13719</ArticleId><ArticleId IdType="pmc">PMC7382021</ArticleId><ArticleId IdType="pubmed">32706371</ArticleId></ArticleIdList></Reference><Reference><Citation>Salih D.A., Bayram S., Guelfi S., et al. Genetic variability in response to amyloid beta deposition influences Alzheimer&#x2019;s disease risk. Brain Commun. 2019;1(fcz022) doi: 10.1093/braincomms/fcz022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcz022</ArticleId><ArticleId IdType="pmc">PMC7145452</ArticleId><ArticleId IdType="pubmed">32274467</ArticleId></ArticleIdList></Reference><Reference><Citation>De Toma I., Dierssen M. Network analysis of down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19. Sci. Rep. 2021;11(1):1930. doi: 10.1038/s41598-021-81451-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-81451-w</ArticleId><ArticleId IdType="pmc">PMC7820501</ArticleId><ArticleId IdType="pubmed">33479353</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemani K., Li C., Olfson M., et al. Association of Psychiatric Disorders with Mortality among Patients with COVID-19. JAMA Psychiatry. 2021 doi: 10.1001/jamapsychiatry.2020.4442. Published online January 27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2020.4442</ArticleId><ArticleId IdType="pmc">PMC7841576</ArticleId><ArticleId IdType="pubmed">33502436</ArticleId></ArticleIdList></Reference><Reference><Citation>Crespo-Facorro B., Ruiz-Veguilla M., V&#xe1;zquez-Bourgon J., et al. Aripiprazole as a candidate treatment of COVID-19 identified through genomic analysis. Front. Pharmacol. 2021;12 doi: 10.3389/fphar.2021.646701.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.646701</ArticleId><ArticleId IdType="pmc">PMC7982825</ArticleId><ArticleId IdType="pubmed">33762960</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Li M., Wang M., et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc. Neurol. 2020 doi: 10.1136/svn-2020-000431. Published online July 2. svn.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/svn-2020-000431</ArticleId><ArticleId IdType="pmc">PMC7371480</ArticleId><ArticleId IdType="pubmed">32616524</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsanos A.H., Palaiodimou L., Zand R., et al. The impact of SARS-CoV-2 on stroke epidemiology and care: a meta-analysis. Ann. Neurol. 2021;89(2):380&#x2013;388. doi: 10.1002/ana.25967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25967</ArticleId><ArticleId IdType="pmc">PMC7753413</ArticleId><ArticleId IdType="pubmed">33219563</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahjouei S., Naderi S., Li J., et al. Risk of stroke in hospitalized SARS-CoV-2 infected patients: a multinational study. EBioMedicine. 2020;59 doi: 10.1016/j.ebiom.2020.102939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102939</ArticleId><ArticleId IdType="pmc">PMC7429203</ArticleId><ArticleId IdType="pubmed">32818804</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaunmuktane Z., Mahadeva U., Green A., et al. Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19. Acta Neuropathol. (Berl.) 2020 doi: 10.1007/s00401-020-02190-2. Published online July 8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02190-2</ArticleId><ArticleId IdType="pmc">PMC7340758</ArticleId><ArticleId IdType="pubmed">32638079</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsivgoulis G., Palaiodimou L., Zand R., et al. COVID-19 and cerebrovascular diseases: a comprehensive overview. Ther. Adv. Neurol. Disord. 2020;13 doi: 10.1177/1756286420978004. 1756286420978004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1756286420978004</ArticleId><ArticleId IdType="pmc">PMC7727052</ArticleId><ArticleId IdType="pubmed">33343709</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z., Flammer A.J., Steiger P., et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417&#x2013;1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#x105;secka A., Borovac J.A., Guerreiro R.A., et al. Thrombotic complications in patients with COVID-19: pathophysiological mechanisms, diagnosis, and treatment. Cardiovasc. Drugs Ther. 2020 doi: 10.1007/s10557-020-07084-9. Published online October 19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10557-020-07084-9</ArticleId><ArticleId IdType="pmc">PMC7569200</ArticleId><ArticleId IdType="pubmed">33074525</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Xiao M., Zhang S., et al. Coagulopathy and Antiphospholipid antibodies in patients with Covid-19. N. Engl. J. Med. 2020;382(17) doi: 10.1056/NEJMc2007575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2007575</ArticleId><ArticleId IdType="pmc">PMC7161262</ArticleId><ArticleId IdType="pubmed">32268022</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemasian H., Ansari B. First case of Covid-19 presented with cerebral venous thrombosis: a rare and dreaded case. Rev. Neurol. (Paris) 2020;176(6):521&#x2013;523. doi: 10.1016/j.neurol.2020.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2020.04.013</ArticleId><ArticleId IdType="pmc">PMC7211601</ArticleId><ArticleId IdType="pubmed">32414532</ArticleId></ArticleIdList></Reference><Reference><Citation>Mowla A., Shakibajahromi B., Shahjouei S., et al. Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series. J. Neurol. Sci. 2020;419:117183. doi: 10.1016/j.jns.2020.117183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117183</ArticleId><ArticleId IdType="pmc">PMC7556283</ArticleId><ArticleId IdType="pubmed">33075595</ArticleId></ArticleIdList></Reference><Reference><Citation>von Weyhern C.H., Kaufmann I., Neff F., Kremer M. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes. Lancet Lond. Engl. 2020;395(10241) doi: 10.1016/S0140-6736(20)31282-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31282-4</ArticleId><ArticleId IdType="pmc">PMC7272176</ArticleId><ArticleId IdType="pubmed">32505222</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharifi-Razavi A., Karimi N., Rouhani N. COVID-19 and intracerebral haemorrhage: causative or coincidental? New Microbes New Infect. 2020;35:100669. doi: 10.1016/j.nmni.2020.100669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmni.2020.100669</ArticleId><ArticleId IdType="pmc">PMC7163302</ArticleId><ArticleId IdType="pubmed">32322398</ArticleId></ArticleIdList></Reference><Reference><Citation>Dogra S., Jain R., Cao M., et al. Hemorrhagic stroke and anticoagulation in COVID-19. J. Stroke Cerebrovasc. Dis. 2020;29(8):104984. doi: 10.1016/j.jstrokecerebrovasdis.2020.104984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2020.104984</ArticleId><ArticleId IdType="pmc">PMC7245254</ArticleId><ArticleId IdType="pubmed">32689588</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhammad S., Petridis A., Cornelius J.F., H&#xe4;nggi D. Letter to editor: severe brain haemorrhage and concomitant COVID-19 infection: a neurovascular complication of COVID-19. Brain Behav. Immun. 2020;87:150&#x2013;151. doi: 10.1016/j.bbi.2020.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.05.015</ArticleId><ArticleId IdType="pmc">PMC7199686</ArticleId><ArticleId IdType="pubmed">32387342</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheruiyot I., Sehmi P., Ominde B., et al. Intracranial hemorrhage in coronavirus disease 2019 (COVID-19) patients. Neurol. Sci. 2020:1&#x2013;9. doi: 10.1007/s10072-020-04870-z. Published online November 3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04870-z</ArticleId><ArticleId IdType="pmc">PMC7605899</ArticleId><ArticleId IdType="pubmed">33140308</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke C., Ferse C., Kreye J., et al. High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms. Brain Behav. Immun. 2020 doi: 10.1016/j.bbi.2020.12.022. Published online December 24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.12.022</ArticleId><ArticleId IdType="pmc">PMC7834471</ArticleId><ArticleId IdType="pubmed">33359380</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenembaum S., Chitnis T., Ness J., Hahn J.S., International Pediatric MS Study Group Acute disseminated encephalomyelitis. Neurology. 2007;68(16 Suppl 2):S23&#x2013;S36. doi: 10.1212/01.wnl.0000259404.51352.7f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000259404.51352.7f</ArticleId><ArticleId IdType="pubmed">17438235</ArticleId></ArticleIdList></Reference><Reference><Citation>Novi G., Rossi T., Pedemonte E., et al. Acute disseminated encephalomyelitis after SARS-CoV-2 infection. Neurol. Neuroimmunol. Neuroinflam. 2020;7(5) doi: 10.1212/NXI.0000000000000797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000797</ArticleId><ArticleId IdType="pmc">PMC7286650</ArticleId><ArticleId IdType="pubmed">32482781</ArticleId></ArticleIdList></Reference><Reference><Citation>Utukuri P.S., Bautista A., Lignelli A., Moonis G. Possible acute disseminated encephalomyelitis related to severe acute respiratory syndrome coronavirus 2 infection. Am. J. Neuroradiol. 2020 doi: 10.3174/ajnr.A6714. Published online July 16.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A6714</ArticleId><ArticleId IdType="pmc">PMC7583107</ArticleId><ArticleId IdType="pubmed">32675341</ArticleId></ArticleIdList></Reference><Reference><Citation>McCuddy M., Kelkar P., Zhao Y., Wicklund D. Acute demyelinating encephalomyelitis (ADEM) in COVID-19 infection: a case series. Neurol. India. 2020;68(5):1192&#x2013;1195. doi: 10.4103/0028-3886.299174.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0028-3886.299174</ArticleId><ArticleId IdType="pubmed">33109874</ArticleId></ArticleIdList></Reference><Reference><Citation>Langley L., Zeicu C., Whitton L., Pauls M. Acute disseminated encephalomyelitis (ADEM) associated with COVID-19. BMJ Case Rep. CP. 2020;13(12) doi: 10.1136/bcr-2020-239597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-239597</ArticleId><ArticleId IdType="pmc">PMC10577777</ArticleId><ArticleId IdType="pubmed">33318286</ArticleId></ArticleIdList></Reference><Reference><Citation>Karapanayiotides T., Geka E., Prassopoulos P., et al. Concentric demyelination pattern in COVID-19-associated acute haemorrhagic leukoencephalitis: a lurking catastrophe? Brain J. Neurol. 2020;143(12) doi: 10.1093/brain/awaa375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa375</ArticleId><ArticleId IdType="pmc">PMC7665315</ArticleId><ArticleId IdType="pubmed">33064796</ArticleId></ArticleIdList></Reference><Reference><Citation>Takai Y., Misu T., Nishiyama S., et al. Hypoxia-like tissue injury and glial response contribute to Balo concentric lesion development. Neurology. 2016;87(19):2000&#x2013;2005. doi: 10.1212/WNL.0000000000003308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003308</ArticleId><ArticleId IdType="pmc">PMC5109956</ArticleId><ArticleId IdType="pubmed">27733565</ArticleId></ArticleIdList></Reference><Reference><Citation>Virani A., Rabold E., Hanson T., et al. Guillain-Barr&#xe9; syndrome associated with SARS-CoV-2 infection. IDCases. 2020;20 doi: 10.1016/j.idcr.2020.e00771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idcr.2020.e00771</ArticleId><ArticleId IdType="pmc">PMC7165113</ArticleId><ArticleId IdType="pubmed">32313807</ArticleId></ArticleIdList></Reference><Reference><Citation>Filosto M., Piccinelli S.C., Gazzina S., et al. Guillain-Barr&#xe9; syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions. J. Neurol. Neurosurg. Psychiatry. 2020 doi: 10.1136/jnnp-2020-324837. Published online November 6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-324837</ArticleId><ArticleId IdType="pubmed">33158914</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez-Ortiz C., M&#xe9;ndez A., Rodrigo-Rey S., et al. Miller fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020 doi: 10.1212/WNL.0000000000009619. Published online April 17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009619</ArticleId><ArticleId IdType="pubmed">32303650</ArticleId></ArticleIdList></Reference><Reference><Citation>Keddie S., Pakpoor J., Mousele C., et al. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barre syndrome. medRxiv. 2020 doi: 10.1101/2020.07.24.20161471. Published online July 24. 2020.07.24.20161471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.24.20161471</ArticleId><ArticleId IdType="pmc">PMC7799186</ArticleId><ArticleId IdType="pubmed">33313649</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunn M.P., Cornblath D.R., Jacobs B.C., et al. COVID-19 vaccine and Guillain-Barr&#xe9; syndrome: let&#x2019;s not leap to associations. Brain J. Neurol. 2020 doi: 10.1093/brain/awaa444. Published online December 14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa444</ArticleId><ArticleId IdType="pmc">PMC7799242</ArticleId><ArticleId IdType="pubmed">33313690</ArticleId></ArticleIdList></Reference><Reference><Citation>Garnero M., Del Sette M., Assini A., et al. COVID-19-related and not related Guillain-Barr&#xe9; syndromes share the same management pitfalls during lock down: the experience of Liguria region in Italy. J. Neurol. Sci. 2020;418:117114. doi: 10.1016/j.jns.2020.117114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117114</ArticleId><ArticleId IdType="pmc">PMC7462770</ArticleId><ArticleId IdType="pubmed">32947089</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindan C.E., Mankad K., Ram D., et al. Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study. Lancet Child Adolesc Health. 2020 doi: 10.1016/S2352-4642(20)30362-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(20)30362-X</ArticleId><ArticleId IdType="pmc">PMC7744016</ArticleId><ArticleId IdType="pubmed">33338439</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao A., Rohaut B., Le Guennec L., et al. Severe COVID-19-related encephalitis can respond to immunotherapy. Brain. 2020;143(12):e102. doi: 10.1093/brain/awaa337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa337</ArticleId><ArticleId IdType="pmc">PMC7665364</ArticleId><ArticleId IdType="pubmed">33064794</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A., Masciocchi S., Volonghi I., et al. SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses. Clin. Infect. Dis. 2021:ciaa1933. doi: 10.1093/cid/ciaa1933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1933</ArticleId><ArticleId IdType="pmc">PMC7799260</ArticleId><ArticleId IdType="pubmed">33395482</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal Y.M., Abdelmajid Y., Madani A.A.R.A. Cerebrospinal fluid confirmed COVID-19-associated encephalitis treated successfully. BMJ Case Rep. CP. 2020;13(9) doi: 10.1136/bcr-2020-237378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-237378</ArticleId><ArticleId IdType="pmc">PMC7497137</ArticleId><ArticleId IdType="pubmed">32938656</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y.H., Jiang D., Huang J.T. SARS-CoV-2 detected in cerebrospinal fluid by PCR in a case of COVID-19 encephalitis. Brain Behav. Immun. 2020;87:149. doi: 10.1016/j.bbi.2020.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.05.012</ArticleId><ArticleId IdType="pmc">PMC7202824</ArticleId><ArticleId IdType="pubmed">32387508</ArticleId></ArticleIdList></Reference><Reference><Citation>Crunfli F., Carregari V.C., Veras F.P., et al. SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viability. medRxiv. 2021 doi: 10.1101/2020.10.09.20207464. Published online February 7. 2020.10.09.20207464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.09.20207464</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirzaee S.M.M., Gon&#xe7;alves F.G., Mohammadifard M., Tavakoli S.M., Vossough A. Focal cerebral Arteriopathy in a pediatric patient with COVID-19. Radiology. 2020;297(2):E274&#x2013;E275. doi: 10.1148/radiol.2020202197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020202197</ArticleId><ArticleId IdType="pmc">PMC7587294</ArticleId><ArticleId IdType="pubmed">32484418</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Mannan O., Eyre M., L&#xf6;bel U., et al. Neurologic and radiographic findings associated with COVID-19 infection in children. JAMA Neurol. 2020 doi: 10.1001/jamaneurol.2020.2687. Published online July 1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2687</ArticleId><ArticleId IdType="pmc">PMC7330822</ArticleId><ArticleId IdType="pubmed">32609336</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27(4):601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Gemelli against COVID-19 post-acute care study group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S.J., McIvor C., Whyatt G., et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J. Med. Virol. 2020 doi: 10.1002/jmv.26368. Published online July 30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Cassar M.P., Tunnicliffe E.M., et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. medRxiv. 2020 doi: 10.1101/2020.10.15.20205054. Published online October 18. 2020.10.15.20205054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.15.20205054</ArticleId><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J.P., Chesney E., Oliver D., et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611&#x2013;627. doi: 10.1016/S2215-0366(20)30203-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M., Schommers P., Stecher M., et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health &#x2013; Eur. 2021;6 doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Gousseff M., Penot P., Gallay L., et al. Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound? J. Inf. Secur. 2020 doi: 10.1016/j.jinf.2020.06.073. Published online June 30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.06.073</ArticleId><ArticleId IdType="pmc">PMC7326402</ArticleId><ArticleId IdType="pubmed">32619697</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C., Lee K., Ni Lochlainn M., et al. 2020. Symptom Clusters in COVID-19: A Potential Clinical Prediction Tool from the COVID Symptom Study App. Published online June 16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.12.20129056</ArticleId><ArticleId IdType="pmc">PMC7978420</ArticleId><ArticleId IdType="pubmed">33741586</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., et al. Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App. medRxiv. 2020 doi: 10.1101/2020.10.19.20214494. Published online December 19. 2020.10.19.20214494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.19.20214494</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E., Schiabor Barrett K., Riffle S., et al. 2020. Long-Term COVID-19 Symptoms in a Large Unselected Population. Published online October 11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.07.20208702</ArticleId></ArticleIdList></Reference><Reference><Citation>Report: What Does COVID-19 Recovery Actually Look Like? Patient Led Research; 2021. https://patientresearchcovid19.com/research/report-1/ Accessed December 30, 2020.</Citation></Reference><Reference><Citation>Carvalho-Schneider C., Laurent E., Lemaignen A., et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin. Microbiol. Infect. 2020 doi: 10.1016/j.cmi.2020.09.052. Published online October 5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Vladutiu G.D., Natelson B.H. Association of medically unexplained fatigue with ACE insertion/deletion polymorphism in gulf war veterans. Muscle Nerve. 2004;30(1):38&#x2013;43. doi: 10.1002/mus.20055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20055</ArticleId><ArticleId IdType="pubmed">15221876</ArticleId></ArticleIdList></Reference><Reference><Citation>Law R.K.Y., Lee E.W.C., Poon P.Y.H., Lau T.C.H., Kwok K.M.L., Chan A.C.M. The functional capacity of healthcare workers with history of severe acute respiratory distress syndrome (SARS) complicated with avascular necrosis--case report. Work Read Mass. 2008;30(1):17&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">18198435</ArticleId></ArticleIdList></Reference><Reference><Citation>Tansey C.M., Louie M., Loeb M., et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch. Intern. Med. 2007;167(12):1312&#x2013;1320. doi: 10.1001/archinte.167.12.1312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.167.12.1312</ArticleId><ArticleId IdType="pubmed">17592106</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., De Lorenzo R., Conte C., et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav. Immun. 2020;89:594&#x2013;600. doi: 10.1016/j.bbi.2020.07.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.07.037</ArticleId><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>